Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Trends, By The Business Research Company
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023 By The Business Research Company describes and explains the artificial intelligence (AI) in drug discovery market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report cover market sizing information, market trends, strategies, and opportunities for the seven regions and major players of the AI In Drug Discovery market
LONDON, Feb. 9, 2023 /PRNewswire/ -- According to The Business Research Company's AI In Drug Discovery Global Market Report 2023, the global artificial intelligence (AI) in drug discovery market is concentrated with a large number of players. The top ten competitors in the market made up to more than 50% of the total artificial intelligence (AI) in drug discovery market. This is due to the growing number of applications that address target and drug discovery, preclinical and clinical development, and post approval activities.
The IBM Corporation was the largest competitor with 13.33% share of the artificial intelligence (AI) in drug discovery market, as per the artificial intelligence (AI) in drug discovery market analysis. Other major players in the artificial intelligence (AI) in drug discovery market include Benevolent AI, Nvidia Corporation, Exscientia, Concreto HealthAI, PathAI, BERG, GNS Healthcare, Microsoft Corporation, Insilico Medicine, and more. Several companies in the market have begun using artificial intelligence (AI) tools for tracking medication adherence.
For example, Groove Health, a US based digital health company launched an AI-powered mobile app to help Payers and Health Systems improve medication adherence in their chronic disease populations, addressing the behavioural aspects of medication non-adherence.
Learn more on the Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023
The artificial intelligence (AI) in drug discovery market is expected to grow from $791.8 million in 2023 to $2.9 billion in 2027 at a rate of more than 30%.
AI In Drug Discovery Global Market Report 2023 segments the market
To take advantage of these opportunities, The Business Research Company recommends companies in the artificial intelligence (AI) in drug discovery market to focus on use of AI based models in pre-clinical studies and introducing new AI tools for drug discovery and rare diseases treatment.
Global Artificial Intelligence (AI) In Drug Discovery Market Strategy Recommendations -
Contact us for strategies that are tailored for you - https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp
View Similar Reports
Artificial Intelligence Global Market Report 2023
Drug Discovery Global Market Report 2023
Artificial Intelligence Chip Global Market Report 2023
Interested to know more about The Business Research Company?
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
The World's Most Comprehensive Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users make better strategic decisions.
The Business Research Company
Follow Us On:
View original content:https://www.prnewswire.co.uk/news-releases/global-artificial-intelligence-ai-in-drug-discovery-market-competitive-landscape-and-trends-by-the-business-research-company-301742692.html